— Know what they know.
Not Investment Advice
Also trades as: 0J9P.L (LSE) · $vol 0M

INCY NASDAQ

Incyte Corporation
1W: +0.1% 1M: -8.5% 3M: -12.8% YTD: +11.7% 1Y: +26.9% 3Y: +103.7% 5Y: +75.5%
$116.60
+3.29 (+2.90%)
After Hours: $116.00 (-0.60, -0.51%)
Weekly Expected Move ±4.1%
$106 $111 $116 $120 $125
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 46 · $23.0B mcap · 201M float · 0.850% daily turnover · Short 79% of daily vol
Credit Risk of going bust: lower than 96% of companies Debt: 0.2% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.01 (down more than 99.9%), Incyte Corporation would be worth roughly what it owes.
Total debt $38.3M against a stock market value of $22.97B.
Distance to default 21.13 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $19.1M (short-term plus half of long-term), stock volatility 33.5%; Altman Z'' 10.50. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Balance Sheet Trends

Total Assets
$7.0B +27.8% ▲
5Y CAGR: +14.3%
Total Liabilities
$1.8B -9.7% ▼
5Y CAGR: +13.7%
Shareholders Equity
$5.2B +49.9% ▲
5Y CAGR: +14.6%
Cash & Investments
$3.6B +65.9% ▲
5Y CAGR: +14.7%
Total Debt
$69M +59.4% ▲
5Y CAGR: +7.9%
Net Debt
-$3.0B -84.2% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$2.1B$3.0B$3.2B$1.7B$3.1B
Short-Term Investments$291M$288M$443M$470M$483M
Cash & ST Investments$2.3B$3.2B$3.7B$2.2B$3.6B
Net Receivables$616M$645M$744M$853M$1.0B
Inventory$28M$42M$63M$59M$101M
Other Current Assets$0$167M$183M$169M$318M
Total Current Assets$3.1B$4.1B$4.6B$3.2B$5.0B
Property, Plant & Equip.$751M$766M$777M$794M$758M
Goodwill & Intangibles$306M$285M$279M$269M$250M
Long-Term Investments$221M$134M$188M$19M$48M
Other Non-Current Assets$68M$106M$261M$361M-$48M
Total Non-Current Assets$1.8B$1.7B$2.1B$2.2B$1.5B
Total Assets$4.9B$5.8B$6.8B$5.4B$7.0B
— Liabilities —
Accounts Payable$172M$278M$110M$197M$210M
Short-Term Debt$0$0$0$0$10M
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$328M$436M$545M$725M$1.1B
Total Current Liabilities$854M$1.2B$1.2B$1.6B$1.5B
Long-Term Debt$0$0$0$0$15M
Other Non-Current Liab.$277M$284M$323M$321M$216M
Total Non-Current Liabilities$309M$314M$352M$355M$288M
Total Liabilities$1.2B$1.5B$1.6B$2.0B$1.8B
— Equity —
Common Stock$221K$223K$224K$193K$198K
Retained Earnings-$778M-$437M$160M-$1.1B$214M
Accumulated OCI-$19M$15M$13M-$13M$25M
Total Stockholders Equity$3.8B$4.4B$5.2B$3.4B$5.2B
Total Liabilities & Equity$4.9B$5.8B$6.8B$5.4B$7.0B
— Key Metrics —
Total Debt$45M$41M$38M$44M$69M
Net Debt-$2.0B-$2.9B-$3.2B-$1.6B-$3.0B
Total Investments$512M$421M$630M$489M$531M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms